Personal Wealth Partners Abb Vie Inc. Transaction History

Personal Wealth Partners

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $329,599 - $419,029	-2,395 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $3,051 - $3,399	29 Added 1.23%	2,395 $270,000
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $10,302 - $13,909	-128 Reduced 5.13%	2,366 $254,000
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $10,996 - $12,906	128 Added 5.41%	2,494 $218,000
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $173,593 - $232,293	2,366 New	2,366 $232,000
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $154,026 - $233,522	-2,388 Closed	0 $0
Q3 2019 Oct 22, 2019	BUY	$62.98 - $75.72 $64,617 - $77,688	1,026 Added 75.33%	2,388 $181,000
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $89,483 - $114,380	1,362 New	1,362 $99,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Personal Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Personal Wealth Partners with notifications on news.